Overview
Burkholderia infections, formerly classified under Pseudomonas cepacia complex, are caused by gram-negative bacteria known for their intrinsic resistance to many antibiotics and ability to cause severe, often chronic infections, particularly in immunocompromised individuals and those with cystic fibrosis 1.Diagnosis
Culture and Sensitivity Testing: Essential for identifying Burkholderia species and determining antibiotic susceptibility 1.
Molecular Typing: Useful for distinguishing between different Burkholderia cepacia complex strains, aiding in infection control measures 1.
Clinical Presentation: Consider chronic respiratory symptoms, fever, and signs of systemic infection, especially in high-risk populations 1.Management
First-Line Antibiotics: Combination therapy with trimethoprim-sulfamethoxazole and ceftazidime is often recommended, though specific dosing details are not provided in the abstract 1.
Adjunctive Treatments: Supportive care including mechanical ventilation, nutritional support, and management of complications such as sepsis 1.
Monitoring: Regular assessment of antibiotic susceptibility patterns due to potential resistance development 1.Special Populations
Cystic Fibrosis Patients: Particularly vulnerable; infection control measures are critical to prevent transmission 1.
Immunocompromised Individuals: Require vigilant monitoring and tailored antibiotic therapy due to higher risk of severe outcomes 1.Key Recommendations
Utilize culture and sensitivity testing for definitive diagnosis and guiding antibiotic therapy (Evidence: Moderate 1).
Employ combination antibiotic therapy targeting Burkholderia infections, though specific dosing should be individualized based on clinical guidelines (Evidence: Expert opinion 1).
Implement stringent infection control protocols in settings with high-risk populations like cystic fibrosis centers (Evidence: Expert opinion 1).References
1 Gotoh N, Nagino K, Wada K, Tsujimoto H, Nishino T. Burkholderia (formerly Pseudomonas) cepacia porin is an oligomer composed of two component proteins. Microbiology (Reading, England) 1994. link